Clinical Trials Directory

Trials / Completed

CompletedNCT04516213

Study to Evaluate the Tolerance and Safety of a Peptide-based Enteral Formula with Partially Hydrolyzed Guar Gum (PHGG)

An Open-label, Single-arm Study to Evaluate the Tolerance and Safety of a Peptide-based Enteral Formula with Partially Hydrolyzed Guar Gum (PHGG) in the Nutritional Management of Tube-fed Children Aged 1-4 Years.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Société des Produits Nestlé (SPN) · Industry
Sex
All
Age
1 Year – 4 Years
Healthy volunteers
Not accepted

Summary

This is a Multicenter, Open-label, Single-arm study evaluating the Tolerance and Safety of a Peptide-based Enteral Formula with Partially Hydrolyzed Guar Gum (PHGG) in the Nutritional Management of Tube-fed Children Aged 1-4 Years over a 7 day period.

Conditions

Interventions

TypeNameDescription
OTHEREnteral Formula With (PHGG)Pediatric subjects will be fed a Peptide-based Enteral Formula With Partially Hydrolyzed Guar Gum (PHGG)

Timeline

Start date
2020-02-28
Primary completion
2021-06-01
Completion
2021-06-01
First posted
2020-08-18
Last updated
2024-10-15

Locations

5 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT04516213. Inclusion in this directory is not an endorsement.